国际皮肤性病学杂志    2006 32 (5): 303-305   ISSN: 2096-5540  CN: 32-1880/R   CC型趋化因子与慢性荨麻疹 唐慧, 徐金华, 郑志忠 复旦大学附属华山医院皮肤科, 上海200040 收稿日期 2006-03-09  修回日期 null  网络版发布日期 null 参考文献  [1] Zuberbier T,Greaves MW,Juhlin L,et al.Definition,classification,and routine diagnosis of urticaria:a consensus report.J Investig Dermatol Symp Proc,2001,6:123-127. [2] Miyamasu M,Yamaguchi M,Nakajima T,et al.Th1-derived cytokine IFN-gamma is a potent inhibitor of eotaxin synthesis in vitro.Int Immunol,1999,11:1001-1004. [3] Togawa M,Kiniwa M,Nagai H.The roles of IL-4,IL-5 and mast cells in the accumulation of eosinophils during allergic cutaneous late phase reaction in mice.Life Sci,2001,69:699-705. [4] Caproni M,Volpi W,Macchia D,et al.Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test.Exp Dermatol,2003,12:621-628. [5] Piconi S,Trabattoni D,Iemoli E,et al.Immune profiles of patients with chronic idiopathic urticaria.Int Arch Allergy Immunol,2002,128:59-66. [6] Zweiman B,Kaplan AP,Tong L,et al.Cytokine levels and inflammatory responses in developing late-phase allergic reactions in the skin.J Allergy Clin Immunol,1997,100:104-109. [7] Beck LA,Dalke S,Leiferman KM,et al.Cutaneous injection of RANTES causes eosinophil recruitment:comparison of nonallergic and allergic human subjects.J Immunol,1997,159:2962-2972. [8] Ying S,Robinson DS,Meng Q,et al.C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects:association of eotaxin with early 6-hour eosinophils,and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia,and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).J Immunol,1999,163:3976-3984. [9] Menzies-Gow A,Ying S,Sabroe I,et al.Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils,basophils,neutrophils,and macrophages as well as features of early-and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers.J Immunol,2002,169:2712-2718. [10] Menzies-Gow A,Ying S,Phipps S,et al.Interactions between eotaxin,histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans.Clin Exp Allergy,2004,34:1276-1282. [11] Borchers MT,Ansay T,DeSalle R,et al.In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration.J Leukoc Biol,2002,71:1033-1041. [12] Powell WS,Ahmed S,Gravel S,et al.Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis.J Allergy Clin Immunol,2001,107:272-278. [13] Yamamoto H,Nagata M,Sakamoto Y.CC chemokines and transmigration of eosinophils in the presence of vascular cell adhesion molecule 1.Ann Allergy Asthma Immunol,2005,94:292-300. [14] Ferrer M,Luquin E,Sanchez-Ibarrola A,et al.Secretion of cytokines,histamine and leukotrienes in chronic urticaria.Int Arch Allergy Immunol,2002,129:254-260. [15] Reale M,Barbacane RC,DiGioacchino M,et al.Differential expression and secretion of RANTES and MCP-1 in activated peripheral blood mononuclear cell cultures of atopic subjects.Immunol Lett,2001,76:7-14. [16] Banwell ME,Tolley NS,Williams TJ,et al.Regulation of human eotaxin-3/CCL26 expression:modulation by cytokines and glucocorticoids.Cytokine,2002,17:317-323. [17] Fahy O,Porte H,Senechal S,et al.Chemokine-induced cutaneous inflammatory cell infiltration in a model of Hu-PBMC-SCID mice grafted with human skin.Am J Pathol,2001,158:1053-1063. [18] Sebastiani S,Allavena P,Albanesi C,et al.Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.J Immunol,2001,166:996-1002. [19] Jinquan T,Quan S,Feili G,et al.Eotaxin activates T cells to chemotaxis and adhesion only ifinduced to express CCR3 by IL-2 together with IL-4.J Immunol,1999,162:4285-4292. [20] Suzuki K,Morokata T,Morihira K,et al.In vitro and in vivo characterization of a novel CCR3 antagonist,YM-344031.Biochem Biophys Res Commun,2006,339:1217-1223. 通讯作者: 徐金华,email:xjhhs@medmail.com.cn